Introduction
SRY-box 2 (Sox2) is a SoxB1 HMG domain transcription factor critical for establishing and maintaining the pluripotency of embryonic stem cells (1, 2) and, in combination with other defined factors, induces pluripotent stem cells (3, 4) . Sox2 also directs cellular differentiation in multiple developing organs, including the CNS (5-9), retina (10), cochlea (11) , hair follicles (12) , lens (13) , and the foregut and its derivatives (14) (15) (16) (17) . Besides designating tissuespecific progenitors in these developing organs, Sox2 governs cell specification (10, 11, 17,) with deficiencies leading to anophthalmia and epilepsy as well as trachea-esophageal and genital anomalies in both mice and humans (10, (17) (18) (19) (20) .
Sox2-expressing somatic stem cells are widely distributed in adult animals and are essential for tissue homeostasis and repair (16, (21) (22) (23) . For example, Sox2 loss of function impairs adult neurogenesis and tracheal repair (16, (24) (25) (26) . Moreover, Sox2 is upregulated during spinal cord regeneration, with damage inducing the proliferation of Sox2 + cells, and inhibition of Sox2 limiting their regeneration in a dose-dependent manner (27) . Thus, the prevailing notion is that Sox2 insufficiency impairs both the development and regeneration of tissues.
In the developing mouse cochlea, Sox2 expression marks the prosensory region, which harbors cells primed to give rise to the mechanosensory hair cells and nonsensory supporting cells of the organ of Corti. Sox2 is required for hair cell specification, as prosensory cells in Sox2-deficient cochleae fail to acquire a hair cell fate (11, 28) . A subset of Sox2 + cells first express the prosensory transcription factor Atoh1 around E13.5 (29) . Specified sensory cells expressing Atoh1 then mature by upregulating Pou4f3, a transcription factor linked with inherited progressive hearing loss in humans (30, 31) , as well as Gfi1 (32) and myosin 7a (33) . Conversely, Sox2 is downregulated in maturing hair cells and becomes undetectable in the early postnatal period, while adjacent supporting cells maintain Sox2 expression (34) . By binding to its enhancer region, Sox2 can directly activate Atoh1 (35) (36) (37) (38) and is sufficient for inducing ectopic sensory hair cells in vitro (38) and in vivo (39) in the embryonic cochlea. A subsequent reduction of Sox2 expression is also necessary for hair cell maturation, as high levels of Sox2 antagonize Atoh1 and prevent hair cell formation when overexpressed in vitro (28, 35) , and Sox2 activates repressors of Atoh1 (40) . Because Sox2 is initially required for hair cell specification and subsequently inhibits hair cell differentiation, its relationship with hair cell formation is coined an "incoherent feed-forward loop" (41) .
Here, we examined the effects of Sox2 haploinsufficiency on cell division and hair cell regeneration in response to damage in the postnatal cochlea. We found that Sox2-haploinsufficient mice had extranumerary cochlear hair cells and normal auditory function in adulthood. Although terminal mitosis normally occurs around E14.5 (42) , supporting cells in the postnatal Sox2-haploinsufficient cochlea still divided. After hair cell ablation in the neonatal cochlea, supporting cells that proliferate and form new hair cells are limited in number and spatially restricted (43) . In the damaged Sox2-haploinsufficient cochlea, we found an increase in and expansion of the domain of dividing (EdU + ) and transitional (Atoh1 + ) supporting cells along the cochlea. Moreover, During development, Sox2 is indispensable for cell division and differentiation, yet its roles in regenerating tissues are less clear. Here, we used combinations of transgenic mouse models to reveal that Sox2 haploinsufficiency (Sox2 haplo ) increases rather than impairs cochlear regeneration in vivo. Sox2 haplo cochleae had delayed terminal mitosis and ectopic sensory cells, yet normal auditory function. Sox2 haplo amplified and expanded domains of damage-induced Atoh1 + transitional cell formation in neonatal cochlea. Wnt activation via β-catenin stabilization (β-catenin GOF ) alone failed to induce proliferation or transitional cell formation. By contrast, β-catenin GOF caused proliferation when either Sox2 haplo or damage was present, and transitional cell formation when both were present in neonatal, but not mature, cochlea. Mechanistically, Sox2 haplo or damaged neonatal cochleae showed lower levels of Sox2 and Hes5, but not of Wnt target genes. Together, our study unveils an interplay between Sox2 and damage in directing tissue regeneration and Wnt responsiveness and thus provides a foundation for potential combinatorial therapies aimed at stimulating mammalian cochlear regeneration to reverse hearing loss in humans.
Sox2 haploinsufficiency primes regeneration and Wnt responsiveness in the mouse cochlea tic emissions (DPOAEs) and found no statistical differences in thresholds between Sox2
CreERT2/+ mice and WT mice at 4 weeks of age ( Figure 1J and Supplemental Figure 1I ). These results demonstrate that Sox2 haploinsufficiency (Sox2 haplo ) leads to delayed terminal mitosis and ectopic inner hair cell formation without compromising auditory function.
Sox2 haplo enhances mitotic regeneration and transitional cell formation. Our prior work showed that supporting cells in the apical turn mitotically regenerate hair cells after hair cell ablation in the neonatal cochlea (43) CreERT2/+ ) cochleae (Figure 2A and Supplemental Figure 3E ). Cochleae from WT animals injected with diphtheria toxin (DT) showed no hair cell loss or EdU-labeled supporting cells (Figure 2, B-D haplo ) cochlea, we found a significantly larger number of EdU-labeled supporting cells (10.3 ± 1.9 per 160 μm) and hair cells (1.5 ± 0.3 per 160 μm) in the apical turn ( Figure 2H ), with EdU-labeled supporting cells also present in the middle turn ( Figure 2I ) but not the basal turn (Figure 2J ). On average, there was a 9.2-fold increase in the total number of EdU-labeled cells in damaged, Sox2 haplo cochleae compared with total numbers in the damaged-only cochleae ( Figure 2K and Supplemental Table 1 ). These results indicate that Sox2 haplo increases the degree and expands the domain of damage-induced proliferation along the length of the cochlea.
Hair cell regeneration in the neonatal mammalian cochlea can also occur without an antecedent mitotic event (43, 45) , through the direct transition of supporting cells into hair cells. We directly assessed the degree of new hair cell formation through immunostaining of damaged cochleae for the transcription factor Atoh1 ( Figure 3 , A and B, and Supplemental Figure 3A) , which is upregulated in nonmitotic hair cell precursors in the regenerating mouse vestibular system (46, 47) . Atoh1 is highly expressed in nascent hair cells in the embryonic cochlea and is rapidly downregulated postnatally (48, 49) . In agreement with previous reports, we detected Atoh1 protein expression in hair cells in the E18.5 cochlea and its reduction in a base-to-apex direction between P0 and P3, with no expression detected in hair cells at P4 or in supporting cells at any of these ages ( Figure 3C and Supplemental Figure  2 , A-L). We examined the P1 Atoh1 GFP/+ cochlea (50) and found a similar apical-basal gradient of GFP expression in hair cells and none in supporting cells (Supplemental Figure 2 , M-O). Two days after DT-induced hair cell loss on P1, we detected Atoh1, Sox2 double-positive supporting cells in the apical and middle turns in damaged-only (Pou4f3 
Results
Sox2 haploinsufficiency leads to ectopic hair cell formation and delayed terminal mitosis. The mammalian cochlea is organized as a checkerboard of hair cells intercalated by Sox2 + supporting cells (34) (Figure 1A) . In the P5 cochlea, Sox2 expression was robust in most supporting cell subtypes (Hensen's cells, Deiters' cells, pillar cells, and inner phalangeal cells) and also in cells residing in the greater epithelial ridge ( Figure 1A ). This pattern was confirmed by Cre reporter expression in Sox2
CreERT2/+ Rosa26R TdTomato/+ cochleae induced on P1 and by GFP expression in Sox2 GFP/+ cochleae ( Figure 1 , B and C) (21) . To determine whether hair cell formation and proliferation are affected by Sox2 haploinsufficiency, we first examined cochleae from Sox2
CreERT2/+ mice ( Figure 1D ). The Sox2 CreERT2/+ mouse was generated as an inserted targeted mutation in the single exon of the Sox2 gene (21) , resulting in Sox2 haploinsufficiency (Sox2 haplo ). We performed quantitative PCR (qPCR) on cochleae from P5 Sox2
CreERT2/+ mice and found a reduction of approximately 27.3% in Sox2 expression relative to WT cochleae ( Figure 1E , P < 0.05). P5 WT cochleae had the normal complement of myosin 7a + hair cells (3 rows of outer hair cells and 1 row of inner hair cells) ( Figure 1F ). In Sox2
CreERT2/+ cochleae, we noted extranumerary myosin 7a + hair cells juxtaposed to inner hair cells ( Figure 1G ) along the length of the cochlea. We also observed ectopic hair cells along the cochleae from a second Sox2-knockin mouse line (Sox2 CreERT2/+ and Sox2 GFP/+ mice, respectively, compared with 3.3 ± 1.5 ectopic hair cells in WT control cochleae ( Figure 1H ).
The last mitotic event in the developing organ of Corti occurs in the basal turn around E14.5 (42) . EdU pulses (P2-P4, Figure 1D ) failed to label any hair cells or supporting cells in the WT cochlea, confirming its mitotic quiescence ( Figure 1F ). With the same EdU regimen ( Figure 1D and Supplemental Figure 1A ), we observed 10.2 ± 4.8 and 22.8 ± 13.8 EdU-labeled supporting cells in the apical turn of Sox2
CreERT2/+ and Sox2 GFP/+ cochleae, respectively ( Figure  1 , G and I, Supplemental Figure 1C , and Supplemental Table 1 ). There were no EdU + supporting cells in the middle or basal turns (Supplemental Figure 1, D and E) . To determine the timing of terminal mitosis in Sox2
CreERT2/+ mice, we delayed the EdU injection schedule by 1 day (P3-P5) and failed to detect any EdU-labeled supporting cells in the organ of Corti (n = 3, data not shown). This indicates that terminal mitosis is delayed until around P2 in the Sox2
CreERT2/+ cochlea. We confirmed this finding by immunostaining for the proliferation marker Ki67 in Sox2
CreERT2/+ and Sox2 GFP/+ cochleae (P4-P5) and found no Ki67 + cells in the organ of Corti (Supplemental Figure 1, F-H) . We also measured the auditory brainstem response (ABR) and distortion product otoacous- Table 2 ). By P4, when cochlear hair cells normally lack Sox2 expression ( Figure 3F ), we found that Atoh1 + myosin 7a + cells also expressed Sox2 and Gfi1 ( Figure 3G ), suggesting that they were supporting cells transitioning into nascent hair cells ( Figure 3B ). Given these findings, we hereafter define Atoh1 +
Sox2
+ cells as CreERT2/+ mice had normal ABR thresholds, comparable to those of their WT littermates. DC, Deiters' cell; GER, greater epithelial ridge; HC, hair cell; IHC, inner hair cell; IP, inner pillar cell; IPhC, inner phalangeal cell; LER, lesser epithelial ridge; OHC, outer hair cell; OP, outer pillar cell; Ortho, orthogonal view; PC, pillar cell; SC, supporting cell. Data represent the mean ± SD. *P < 0.05 and **P < 0.01, by 2-tailed Student's t test. n = 3-8. Scale bar: 20 μm. haplo cochlea with the damaged-only cochlea on P21 (after treatment with DT on P1 and with EdU from P3 to P5) (Supplemental Figure 4A ). As expected, we detected no EdU incorporation in the WT cochlea (Supplemental Figure 4B ). We found that the damaged-only cochlea contained few hair cells among disorganized supporting cells in the apical turn, with occasional EdU labeling of each cell type (Supplemental haplo cochleae than in the damagedonly cochleae. The SD of transitional cell counts in the basal turn of damaged, Sox2 haplo cochleae is zero. Data represent the mean ± SD. *P < 0.05, **P < 0.01, and ***P < 0.001, by 1-way ANOVA with Holm-Sidak multiple comparisons test. n = 3. Scale bars: 20 μm. Figure 4G ). Taken together, these results indicate that Sox2 haplo modestly promotes the survival of regenerated hair cells in the damaged cochlea, but the extent of survival is insufficient to establish auditory function.
Sox2 haplo enhances β-catenin-induced proliferation in the damaged neonatal cochlea. β-Catenin is the central mediator of the canonical Wnt signaling pathway, with exon 3 encoding a domain to be phosphorylated by glycogen synthase 3β. Phosphorylated β-catenin is degraded by the destruction complex, rendering the pathway inactive (52) . In heterozygotes carrying β-catenin lacking exon 3, β-catenin is stabilized, leading to aberrant activation of Wnt signaling, and thus acts as a dominant mutation (53) . Previous studies show that β-catenin stabilization in the neonatal cochlea causes proliferation and ectopic hair cell formation (54, 55) . To further explore its role after damage, we first used 2 Cre-LoxP model systems to enhance Wnt signaling by stabilizing β-catenin in neonatal supporting cells ( Figure 4, A ) cochleae. We observed significantly more (~3.5-fold) EdU-labeled supporting cells and hair cells in the damaged, β-catenin GOF cochleae, a finding that was limited to the apical turn ( Figure 4 , C-E, and I, and Supplemental Table 1 ). This suggests that β-catenin GOF increases mitotic regeneration without expanding its domain to the middle or basal turns.
We next probed the effects of Sox2 haplo on β-catenininduced mitotic regeneration by examining damaged, Sox2
) cochleae. We found many EdU + supporting cells and hair cells in both the apical and middle turns and also observed EdU + supporting cells in the basal turn (Figure 4 , F-I, and Supplemental Table 1 ). In comparison with the damaged, β-catenin GOF cochlea, we observed an additional increase in the number of EdU + supporting cells and hair cells in the apical and middle turns ( Figure 4I and Supplemental Table 1 ). Relative to the damaged, Sox2 haplo cochlea, the damaged, Sox2 haplo , β-catenin GOF cochlea contained more EdU + supporting cells and hair cells in the apical turn only, while the cells in the middle and basal turns were not significantly different (Supplemental Table 1 ). These results indicate that both β-catenin GOF and Sox2 haplo enhanced mitotic regeneration in the apical turn in the damaged cochlea. While Sox2 haplo extended the domain of mitotic regeneration into the middle and basal turns of the damaged cochlea, β-catenin GOF failed to induce proliferation in this region, thus its mitogenic effect is spatially restricted to the apex.
Sox2 haplo acts as a permissive signal for β-catenin-responsive transitional cell formation in the damaged neonatal cochlea. To assess whether β-catenin
GOF also enhances transitional cell formation, we stained for Atoh1 and Gfi1 in the damaged, β-catenin GOF cochlea (P4) and found transitional cells (Atoh1
in the apical and middle turns ( Figure 5, A, B, and D) . However, we detected no transitional cells in the base ( Figure 5F ). Compared with damagedonly cochlea without stabilized β-catenin, fewer transitional cells expressed myosin 7a, although there was no significant change in the total number ( Figure 5H and Supplemental Table  2 ), suggesting that β-catenin GOF alone does not enhance transitional cell formation.
We next assessed whether Sox2 haplo affects β-catenin-induced transitional cell formation and examined damaged, Sox2 haplo , β-catenin GOF cochleae. We detected a robust and significant increase in the number of transitional cells in all 3 cochlear turns compared with cell numbers in damaged, β-catenin GOF or damaged-only (Pou4f3 DTR/+ ) cochleae ( Figure 5, C To directly assess the effects of Sox2 haplo on Wnt signaling, we immunostained for the Wnt target Lef1 (56) . In the P5 WT cochlea, we found that Lef1 expression was restricted to below the basilar membrane, where Wnt-responsive, tympanic border cells reside, as previously described (57), and we detected no expression in the sensory epithelium (Supplemental Figure 6, A-C) . Similarly, we failed to detect Lef1 in the sensory epithelium from β-catenin Figure 6H and Supplemental Figure 5K ). We detected no Atoh1 expression and found that Gfi1 expression was confined to hair cells in cochleae subjected to β-catenin stabilization only 
Sox2
CreERT2/+ Ctnnb1 fl(ex3)/+ cochleae. Data represent the mean ± SD. *P < 0.05 and ***P < 0.001, by 1-way ANOVA with Holm-Sidak multiple comparisons test. n = 3-5. Scale bar: 20 μm. Figure 7I ), suggesting that activated Cre recombinase and β-catenin were effectively modified for stabilization.
In the AG-and DT-damaged cochleae, we detected no EdUlabeled cells within the organ of Corti in the β-catenin GOF Figure 7A ). After drug administration on P21, both damage paradigms led to significant hair cell loss by P28 ( Figure 7 , B-E). AGs caused primarily outer hair cell loss, and DT (Pou4f3
DTR/+
) caused mainly inner hair cell loss. Both damage models showed significantly elevated ABR thresholds, with the AG model also showing higher DPOAE thresholds (Figure 7, F and G) .
To 
Discussion
Sox2 directs the cell cycle and cell fate during the development of diverse tissue types. Complete and partial Sox2 deficiencies cause multiorgan defects including anophthalmia, epilepsy, and trachea-esophageal, cochlear, and genital anomalies in mice and humans (10, 11, (17) (18) (19) (20) . Moreover, some regenerating tissues are sensitive to Sox2 dosage and are dependent on Sox2 activation (10, 17, 27) . Our study shows that Sox2 haploinsufficiency allows essentially normal development of the cochlea. Furthermore, in contrast to the previous notion that Sox2 upregulation promotes tissue regeneration, Sox2 haploinsufficiency primes the cochlea to regenerate in vivo.
Competence and domains of tissue regeneration. In the avian cochlea, 2 mechanisms mediate hair cell regeneration in distinct regions of the organ: nonmitotic, direct transdifferentiation in the abneural region and mitotic regeneration in the neural domain (59) . While the mature mammalian cochlea does not regenerate, fate-mapping studies demonstrate that supporting cells in the neonatal cochlea spontaneously proliferate and form new hair cells after damage (43, 45) . Cox and colleagues showed that proliferation primarily occurred in the apical region, while the fatemapped, immature hair cells were present in all 3 turns of the neonatal cochlea. Given the results of these studies, we hypothesized that proliferation competence and phenotypic conversion (which we characterize as transitional cell formation) are distinct and differentially regulated.
Several findings in our study support the notion that cell proliferation and transitional cell formation are differentially governed. First, while mitotic cells in the Sox2 haplo cochlea mainly resided in the apical turn, we found ectopic hair cells in all 3 cochlear turns. After damage, mitotic regeneration occurred primarily in the apical turn, with transitional (Atoh1 + ) cell formation observed more broadly in the apical and middle turns ( Figure 8F ). Thus, as with Sox2 haplo , damage confers competence in supporting cells to both proliferate and form transitional cells. Moreover, the effects of Sox2 haplo and damage appear additive in conferring to supporting cells the competence to mitotically regenerate and form transitional cells. Building on previous studies showing that Sox2 antagonizes hair cell specification in the embryonic cochlea (11) and inhibits proliferation (60), the current results unveil roles for Sox2 haplo as a positive modulator of mitotic hair cell regeneration and transition cell formation in the damaged postnatal cochlea. However, Sox2 is required during hair cell regeneration in the zebrafish inner ear (61) , and whether Sox2 is similarly indispensable during mammalian hair cell regeneration remains to be determined.
Competence to respond to Wnt activation. In contrast to previous studies (54, 55) , our results indicate that postnatal cochlear supporting cells in a resting, undamaged state are not competent to proliferate or form ectopic hair/transitional cells upon Wnt activation. Rather, damage or Sox2 haplo confers to supporting cells the competence to proliferate in response to Wnt activation. Further, the competence to form additional transitional cells in response to Wnt activation requires the presence of both β-catenin GOF cochleae 1 week after damage (Figure 7 , J-Q, and Supplemental Figure 7 , B-Q), nor did we detect any EdU-labeled cells within the organ of Corti 3 weeks after damage (data not shown). Moreover, BrdU administered via the drinking water for 2 weeks (P23-P37) to AG-damaged Fgfr3-iCre Ctnnb1 fl(ex3)/+ mice also failed to label cells in the organ of Corti (Supplemental Figure 7 , V-X). To assess for transitional cell formation, we immunostained cochleae from AG-treated, Sox2 
Sox2
CreERT2/+ ) ( Figure 8A and Supplemental Figure 8A ). Both the neonatal and mature Sox2 haplo cochleae expressed significantly lower levels of Sox2 (23.1% ± 11.1% and 42.7% ± 29.2%, respectively) when compared with levels in WT tissues (Figure 8 , B and C). We also detected a significant reduction in Sox2 levels in the damaged-only (Pou4f3 CreERT2/+ , 21.4% ± 6.1%) cochleae compared with levels in WT control cochleae ( Figure 8B ). By contrast, Sox2 levels did not significantly change after damage in the mature cochlea ( Figure 8C ).
Neonatal cochleae from Sox2 CreERT2/+ mice had a significant reduction in levels of the Notch target gene Hes5 (47.8% ± 29.9%) relative to levels in WT control cochleae ( Figure 8D ). This decrease was also detected using semiquantitative in situ experiments on sections from Sox2
CreERT2/+ and WT cochleae (Supplemental Figure  9, A-F CreERT2/+ ), we also observed a significant decrease in Hes5 expression (25.4% ± 10.3% and 31.3% ± 10.6%, respectively) ( Figure 8D ). However, no change in Hes5 expression was detected in the mature cochlea ( Figure 8E) . Moreover, we observed no changes in the levels of expression of other Notch target genes (Hes1 and Hey1) in the neonatal or mature cochleae (Supplemental Figure 8 , B-E). We also found no significant changes in the expression of Wnt target genes (Axin2, Lgr5, and Lef1) in the 4 groups of neonatal and mature cochleae examined (Supplemental Figure 8, F-K) . These results suggest that decreased expression in components of the Notch pathway may enin-induced proliferation (67) . This study posits a model in which Sox2 represses the mitogenic and prosensory effects of β-catenin activation, possibly via activation of the Notch signaling effector Hes5. Although we did not detect a significant change in defined Wnt target genes in Sox2 haplo or damaged cochleae, it is also possible that decreased Sox2 expression causes a small degree of disinhibition of Wnt signaling and directly facilitates the effects induced by β-catenin stabilization. In support of our finding of Notch signaling involvement, Sox2 regulates retinal progenitor cell proliferation/ differentiation in a dose-dependent manner via Notch signaling (10) . Moreover, Notch1 deletion enhances β-catenin-induced mitotic generation of hair cells in the neonatal cochlea (68) . Like Sox2, Hes5 suppresses Atoh1 during cochlear development (69, 70), damage and Sox2 haplo . These findings lend additional evidence for the differential regulation of mitotic regeneration and transitional cell formation.
While the context-dependent effects of Wnt activation are known (62) , the mechanisms dictating the permissiveness to respond to β-catenin activation remain poorly understood. A potential mechanism is the differential inhibition of Wnt signaling, a finding noted in intestinal polyposis and hepatic carcinogenesis (63) . Several Sox family transcription factors directly interact with β-catenin to repress Wnt transcriptional responses, while others can enhance Wnt target gene expression (64) . Sox2 represses proliferation in Wnt-driven gastric adenoma formation (65) and cancer (66) , but in other contexts such as breast cancer, it stimulates β-cat- GFP/+ mutant, reverse (5′-GAAGGGCATTTGGTTGTCTCAG-3′). For qPCR, total RNA was isolated with an RNeasy Mini Extraction Kit (QIAGEN), and then cDNA was synthesized using SuperScript VILO cDNA Kit (Invitrogen, Thermo Fisher Scientific). TaqMan Fast Advanced Mix and Assays (Applied Biosystems) were used to perform qPCR reactions on a CFX Connect Real-Time System (Bio-Rad). All qPCR reactions were performed in triplicate, and the relative quantification of gene expression was analyzed using the ΔΔCt method (87). These and Notch inhibition increases Atoh1 expression and hair cell formation in undamaged (71) (72) (73) and damaged neonatal cochleae (74) .
In the postnatal cochlea, Hes5 is highly expressed in Sox2 + supporting cells and becomes downregulated in the mature cochlea (75) (76) (77) . The most notable difference between the neonatal and mature cochleae is that the former had lower expression of Hes5 as a result of Sox2 haplo or damage. By contrast, Hes5 and other Notch target genes were expressed at low levels and were not altered as a result of Sox2 haplo or damage in the mature cochlea, suggesting that they play a significant role in restricting hair cell regeneration in the neonatal, but not the mature cochlea. Thus, Sox2 haplo and damage may coordinate to dictate mitotic regeneration, transitional cell formation, and Wnt responsiveness via Notch signaling in the neonatal cochlea, but not in the mature cochlea ( Figure 8G ) because of age-related changes of these factors. Our results are in agreement with previous reports noting a decline of Hes5 expression in the maturing cochlea (72, 75) . Furthermore, Hes5 and Atoh1 expression remained low in the noise-damaged mature cochlea (77) . Another important consideration is the largely unknown network of transcription factors that act in concert with Sox2 and Hes5 in the neonatal and mature cochlea. Moreover, gene silencing by epigenetic factors occurs as the cochlea develops and matures (78) , thus a more comprehensive investigation in these areas, including further study of the roles of Hes5, should be of interest and may help guide future therapy using Sox2 and Wnt signaling to regenerate the mature cochlea.
Mouse models to study regeneration. The results of this study underscore the potential confounding effects from haploinsufficiency when using knockin mouse models (79) . For example, the Foxg1-Cre mouse line can have brain deficits that probably stem from alterations in proliferation, possibly as a result of haploinsufficiency (80) (81) (82) . In the same vein, the differences between our results and those of previous studies, in which β-catenin stabilization induced proliferation in the nondamaged neonatal cochlea, can be attributed to the knockin mouse lines used (Sox2 CreERT2/+ and Lgr5
CreERT2/+ ) (54, 55) . Moreover, the proliferative cells observed after β-catenin stabilization in Lgr5 + cells in the neonatal cochlea may have originated from inner phalangeal cells medial to the inner hair cells. While the robust proliferation observed in the neonatal Sox2
CreERT2/+ cochlea is affected by Sox2 haploinsufficiency (55, 68, 83) , one should also consider the differences in experimental paradigms used and the supporting cell subtypes examined.
In summary, our results introduce a model system for mammalian hair cell regeneration, in which Sox2 haploinsufficiency enhances regeneration, and reveal the cooperative roles between Sox2 haploinsufficiency and damage in governing mitosis, differentiation, and Wnt responsiveness of hair cell precursors in the neonatal cochlea, probably via components of Notch signaling. These findings illustrate the differential responsiveness of cochlear supporting cells as hair cell progenitors in resting and damaged states. Moreover, these findings demonstrate the possibility of priming supporting cells, without hindering their normal function, to enhance their regenerative ability in response to damage and/or adjuvant therapy such as Wnt activation. Thus, this study should provide insights that will help guide the future design of combinatorial approaches for stimulating mammalian cochlear regeneration to reverse hearing loss. ). To assess proliferation in cochleae from mice treated with BrdU following secondary antibody incubation, tissues were washed with PBS and repermeabilized, after which tissues were incubated with 2N HCl in 0.05% Triton X-100 for 1 hour at room temperature. The tissues were then washed with PBS and blocked and immunostained with anti-BrdU as outlined above. Whole mounts were imaged as Z-stacks on a Zeiss LSM700 confocal microscope, and images were captured using Zen Software (Carl Zeiss) and analyzed with ImageJ (NIH) and Photoshop CS6 (Adobe Systems).
ISH. Tissues were harvested on ice, fixed in 4% PFA overnight, and then embedded for cryosectioning as described previously (57) . Briefly, tissues were sequentially submerged in 10%, 20%, and 30% sucrose prior to tissue embedment and freezing in 100% OCT (Sakura). Tissue sections were hybridized with commercial probes from Advanced Cell Diagnostics according to the manufacturer's instructions for fixed, frozen sections with colorimetric detection (88) . Briefly, sections were washed in 1× PBS for 5 minutes and then treated with H 2 O 2 for 10 minutes. Next, sections were permeabilized using target retrieval reagent and proteinase before hybridization. The following Advanced Cell Diagnostics probes were used: Hes5 (catalog 400991), DapB (catalog 310043), Polr2a (catalog 310451), and Sox2 (catalog 401041). WT and Sox2
CreERT2/+ cochleae were processed in parallel, with sections collected on the same slide and subjected to mRNA detection under identical conditions. Cell quantification. For cell counting, confocal images were analyzed using ImageJ. To quantify EdU-labeled cells and ectopic hair cells in neonatal cochleae, Z-stack images were taken of the whole cochleae, which were divided into apical, middle, and basal turns of equal length, and cells were counted from stacks using ImageJ. Other cell counts in the neonatal and the adult cochleae were performed on representative Z-stack images of individual turns.
Statistics. Data were analyzed using Microsoft Excel and GraphPad Prism Version 7 (GraphPad Software). A 2-tailed Student's t test or ANOVA with post hoc testing was used to calculate statistical significance. A P value of less than 0.05 was considered statistically significant. Data shown in the figures represent the mean ± SD. For all experiments, n values represent the number of animals examined.
Study approval. All experimental protocols were approved by the IACUC of Stanford University.
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